{
  "id": 4985780,
  "title": "Squadron Capital, 10% owner, sells $7.76m in OrthoPediatrics Corp stock",
  "url": "https://urgent.news/2026/09/02/squadron-capital-10-owner-sells-7-76m-in-orthopediatrics-corp-stock",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-09-02T01:01:05.000Z",
  "source": {
    "name": "Investing.com",
    "slug": "investing-com",
    "url": "https://www.investing.com/news/insider-trading-news/squadron-capital-10-owner-sells-776m-in-orthopediatrics-corp-stock-93CH-4885233"
  },
  "original_language": "en",
  "account": "Squadron Capital LLC, which holds a 10% stake in OrthoPediatrics Corp (NASDAQ:KIDS), recently divested a substantial portion of its shares, amounting to $7.76 million, in the company's common stock. The transactions took place on August 28 and September 1, 2026, with shares being sold at a weighted average price of $23.04 to $23.10 per share. The substantial sale, totaling 336,831 shares, was made to generate additional capital for Squadron Capital LLC's other portfolio businesses.\n\nOrthoPediatrics Corp has demonstrated robust financial performance recently, with its stock delivering impressive returns. Over the past year, the stock has surged by 29.5%, and over the past six months, it has gained nearly 20%. However, InvestingPro analysis suggests that the company's value may be overestimated, as its market capitalization sits at $608.6 million.\n\nSquadron Capital LLC's decision to sell shares was strategic, aiming to bolster its financial resources for other investments. The August 28 sale of 326,700 shares, averaging $23.04 per share, reduced the company's beneficial ownership to 6,536,764 shares. The subsequent sale on September 1, involving 10,131 shares at $23.10 per share, further decreased the company's direct beneficial ownership to 6,526,633 shares.\n\nOrthoPediatrics Corp reported a significant surge in its second-quarter revenue, reaching $70.5 million, a 15% increase from the previous year. This growth was driven by strong performance across trauma, deformity, and specialty bracing segments, which compensated for a decline in scoliosis revenue. The company raised its full-year revenue forecast, signaling confidence in its future financial prospects. While OrthoPediatrics Corp's stock price remained stable, the positive earnings report has garnered attention from the financial community, potentially prompting adjustments to analysts' projections.",
  "summary": null,
  "key_points": [
    "Squadron Capital LLC sold $7.76 million worth of OrthoPediatrics Corp stock.",
    "Shares were sold at a weighted average price of $23.04 to $23.10 per share.",
    "The sale reduced Squadron Capital's beneficial ownership to 6,526,633 shares."
  ],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}